Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Tract in Long-Standing Ulcerative Colitis: Report of a Case and Review of the Literature

Int J Surg Pathol. 2018 Aug;26(5):479-483. doi: 10.1177/1066896917752443. Epub 2018 Jan 24.

Abstract

A 37-year-old male with long-standing and extensive ulcerative pancolitis developed a rapidly lethal poorly differentiated neuroendocrine carcinoma (NEC) in the sigmoid colon. Prior biopsies obtained from multiple sites of the colon during endoscopic surveillance showed minimal inflammatory changes and no sign of dysplasia. Patients with inflammatory bowel disease (IBD) are at increased risk of colorectal malignancies, and adenocarcinoma is the most common type of colorectal neoplasm associated with ulcerative colitis and Crohn's disease, but other types of epithelial and nonepithelial tumors have also been described in IBD. NECs arising in the setting of ulcerative colitis are very rare and are reported as anecdotic findings. We describe the clinicopathological features of an IBD-related NEC and review the previously reported cases.

Keywords: cancer; inflammatory bowel disease; neuroendocrine carcinoma; ulcerative colitis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Biomarkers, Tumor / blood
  • Biopsy
  • Carcinoma, Neuroendocrine / blood
  • Carcinoma, Neuroendocrine / diagnostic imaging
  • Carcinoma, Neuroendocrine / etiology
  • Carcinoma, Neuroendocrine / pathology*
  • Colitis, Ulcerative / complications*
  • Colitis, Ulcerative / diagnostic imaging
  • Colitis, Ulcerative / drug therapy
  • Colon, Sigmoid / diagnostic imaging
  • Colon, Sigmoid / pathology*
  • Colonoscopy
  • Fatal Outcome
  • Humans
  • Male
  • Sigmoid Neoplasms / blood
  • Sigmoid Neoplasms / diagnostic imaging
  • Sigmoid Neoplasms / etiology
  • Sigmoid Neoplasms / pathology*
  • Tomography, X-Ray Computed

Substances

  • Anti-Inflammatory Agents
  • Biomarkers, Tumor